NumbSkin Pain Relief Cream Recalled by SeeNext Venture Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
CPSC recall 20724 · announced March 18, 2020 · Seenext Venture · 8,000 units affected
The product
This recall involves NumbSkin pain relief cream with 5% lidocaine. The topical anesthetic cream was sold in 30 grams in a white with blue tube. NumbSkin is printed on the tube. Lot 9238 and a date code of 10/2019 through 09/2020 in a MM/YYYY format is embossed on the tub's thin end. Batch number 9238 is printed on the product packaging.
The hazard
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
What to do (per CPSC)
Consumers should immediately store the pain relief cream in a safe location out of reach of children and contact SeeNext Venture for instructions on how to dispose or return it and to receive a free replacement similar product with a child-resistant cap. Amazon is contacting all known purchasers directly. Remedy type: Replace
Notes
Incidents (per CPSC): None reported.
Sold at: Online at Amazon.com from October 2019 through February 2020 for about $25.
Consumer contact: SeeNext Venture toll-free at 844-700-6862 from 9 a.m. to 6 p.m. PT Monday through Saturday, email at distributions@numbskin.com or online at www.numbskin.com and click on Recall at the home page for more information.
Source: U.S. Consumer Product Safety Commission public recall data. This page reports official records and is not legal, medical, or repair advice.